Manic Depression News and Research

RSS

Link between emotional impairment and poor cognition in children with bipolar disorder

Using functional magnetic resonance imaging, Pavuluri and her colleagues examined the brain activity of teens while they were performing certain mental tasks. The researchers scanned the brains of 10 unmedicated bipolar patients with normal mood and compared them with 10 healthy subjects of the same age and gender.

20 Oct 2005

Manic depression linked to two chromosomal regions in the human genome

An international team of 53 researchers has offered the most convincing evidence so far linking bipolar disorder, also known as manic depression, to two chromosomal regions in the human genome. The finding gives scientists refined targets for further gene studies.

19 Sep 2005

Interpersonal and social rhythm therapy is helpful to many people with bipolar disorder

A treatment program that stresses maintaining a regular schedule of daily activities and stability in personal relationships is an effective therapy for bipolar disorder, report University of Pittsburgh School of Medicine researchers in September's Archives of General Psychiatry.

12 Sep 2005

Bipolar survey indicates how patient satisfaction is achieved

Preliminary results from a large-scale global study of people living with bipolar disorder, presented today at the World Congress of Biological Psychiatry (WCBP), found that patient satisfaction with treatment is achieved through combining broad-based efficacy with a favourable tolerability profile.

30 Jun 2005

Results of global bipolar disorder consumer survey

The World Federation for Mental Health (WFMH) today announced results of a global bipolar disorder consumer survey, Thinking Ahead, at the World Congress of Biological Psychiatry.

29 Jun 2005

Bipolar disorder more prevalent and costly than believed

The incidence of bipolar disorder in the general population is considerably higher than earlier studies have indicated, resulting in significantly less productivity and more days lost from work compared to the better known major depressive disorder, according to preliminary findings from a national survey presented today at the Sixth International Conference on Bipolar Disorder.

19 Jun 2005

British surgeons remove part of a woman's brain to cure her epilepsy

Helen Hollis, 41, from Teversal, near Mansfield, Nottingham, a former nurse and the mother of two, had her first seizure aged 19, but had to wait years before her condition was diagnosed.

23 May 2005

Testing new manic depression drugs in slime mould

Research by University College London (UCL) scientists could lead to the development of more effective drugs for treating manic depression thanks to a new screening approach developed in a "slime mould" - a microbe that lives in leaves and dung on forest floors.

23 Apr 2005

Early diagnosis and treatment is important for children and adolescents with bipolar disorder

"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.

22 Feb 2005

New painkiller was discovered in natural form in venomous snails in 1979

The natural form of Prialt – a new drug for severe pain approved this week by the U.S. Food and Drug Administration – was discovered at the University of Utah in 1979 by an incoming freshman studying toxins produced by cone snails.

30 Dec 2004

Transcranial Magnetic Stimulation to treat major depression

Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.

20 Nov 2004

Capsules may be effective in treating bipolar disorder

University of North Carolina at Chapel Hill researchers have announced study results finding that a formulation of three-beaded extended-release carbamazepine capsules (ERC-CBZ) was effective, safe and tolerable in the treatment of bipolar I disorder

19 Nov 2004

Researchers are comparing two drugs used to treat pediatric bipolar disorder

University of Illinois at Chicago researchers are comparing two drugs used to treat pediatric bipolar disorder patients to evaluate how the drugs affect brain function in children with the disorder.

25 Oct 2004

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.

4 Oct 2004

New warnings on antidepressants for children and adolescents highlight the need for appropriate treatments for depression

“Taking an antidepressant comes with risks. When deciding whether an antidepressant is right for a son or daughter, parents should discuss with the physician the possible alternatives, including psychotherapy. Research by the National Institute of Mental Health shows that combining talk therapy and an antidepressant is the most effective treatment for teens battling depression,”

29 Sep 2004

Research suggests that victimisation in childhood increases risk of psychotic disorders, such as schizophrenia or manic depression

People with psychosis report a marked excess of victimising experiences, many of which occurred during childhood, according to a new study.

2 Sep 2004

Common illnesses are associated with an increased risk of suicide in elderly people

Many common illnesses are independently associated with an increased risk of suicide in elderly people, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Jun 2004

Drink that enhances the effectiveness of medication given to treat psychiatric illnesses

Scientists funded by the UK's largest biomedical research charity, The Wellcome Trust, have developed a drink that enhances the effectiveness of medication given to treat psychiatric illnesses such as mania and schizophrenia.

10 Jun 2004